The structure of the nuclear hormone receptors

Steroids

Volumn 64, Issue 5, 1999, Pages 310-319

  Kumar, Raj ^a   Thompson, E Brad ^a  

^a UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

Author keywords

DNA binding domain; Helix; Ligand binding domain; Nuclear receptor; Structure; Transactivation

Indexed keywords

CELL NUCLEUS RECEPTOR; HORMONE RECEPTOR; THYROID HORMONE; TRANSCRIPTION FACTOR;

CARBOXY TERMINAL SEQUENCE; DNA BINDING; HORMONE BINDING; LIGAND BINDING; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION; PROTEIN SECONDARY STRUCTURE; REVIEW; STRUCTURE ANALYSIS; TRANSACTIVATION;

AMINO ACID SEQUENCE; ANIMALS; BINDING SITES; CELL NUCLEUS; DNA; HUMANS; MOLECULAR SEQUENCE DATA; MOLECULAR STRUCTURE; RECEPTORS, CELL SURFACE; RECEPTORS, GLUCOCORTICOID;

EID: 0033054115     PISSN: 0039128X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0039-128X(99)00014-8     Document Type: Review

References (80)

1. Evans R.M. The steroid and thyroid hormone receptor superfamily. Science. 240:(4854):1988;889-895.
2. Beato M. Gene regulation by steroid hormones. Cell. 56:(3):1989;335-344.
3. Koelle M.R., Talbot W.S., Segraves W.A., Bender M.T., Cherbas P., Hogness D.S. The drosophila EcR gene encodes an ecdysone receptor, a new member of the steroid receptor family. Cell. 67:(1):1991;59-77.
4. Yamamoto K.R. Steroid receptor regulated transcription of specific genes and gene network. Ann Rev Genet. 19:1985;209-252.
5. Mangelsdorf D.J., Borgmeyer U., Heyman R.A., Zhou J.Y., Ong E.S., Oro A.E., Kakizuka A., Evans R.M. Characterization of three RXR genes that mediate the action of 9-cis retinoic acid. Genes Dev. 6:(3):1992;329-344.
6. Gustafsson J.A., Carlstedt-Duke J., Poellinger L., Okret S., Wikstrom A.C., Bronnegard M., Gillner M., Dong Y., Fuxe K., Gintra A., Harfstrand A., Agnati L. Biochemistry, molecular biology and physiology of the glucocorticoid receptor. Endocrin Rev. 8:(2):1987;185-234.
7. Tsai M.J., O'Malley B.W. Molecular mechanism of action of steroid/thyroid receptor superfamily members. Annu Rev Biochem. 63:1994;451-486.
8. Truss M., Beato M. Steroid hormone receptors Interaction with DNA and transcription factors . Endocrin Rev. 14:(4):1993;459-479.
9. 3 receptors. Cell. 65:(7):1991;1255-1266.
10. Scheidereit C., Geisse S., Westphal H.M., Beato M. The glucocorticoid receptor binds to defined nucleotide sequences near the promoter of mouse mammary tumor virus. Nature. 304:(5928):1983;749-752.
11. Horwitz K.B., Jackson T.A., Bain D.L., Richer J.A., Takimoto G.S., Tung L. Nuclear receptor coactivators and corepressors. Mol Endocrinol. 10:(10):1996;1167-1177.
12. Schule R., Evans R.M. Cross coupling of signal transduction pathways Zinc finger meets leucine zipper . Trends Genet. 7:(11-12):1991;377-381.
13. Li H., Leo C., Schroen D.J., Chen J.D. Characterization and transcriptional repression by the corepressor SMRT. Mol Endocrinol. 11:(13):1997;2025-2037.
14. Ding X.F., Anderson C.M., Ma H., Hong H., Uht R.M., Kushner P.J., Stallcup M.R. Nuclear receptor binding sites of coactivators glucocorticoid receptor interacting protein-1 (GRIP-1) and steroid receptor coactivator-1 (SRC-1) multiple motifs with different binding specificities. Mol Endocrinol. 12:(2):1998;302-313.
15. Kamei Y., Xu L., Heizel T., Torchia J., Kurokawa R., Gloss B., Lin S.C., Heyman R.A., Rose D.W., Glass C.K., Rosenfeld M.G. A CBP integrator complex mediates transcriptional activation and AP1 inhibition by nuclear receptors. Cell. 85:(3):1996;403-414.
16. Hong H., Kohli K., Trivedi A., Johnson D.L., Stallcup M.R. GRIP1, a novel mouse protein that serves as a transcriptional activator in yeast for the hormone binding domains of steroid receptors. Proc Natl Acad Sci USA. 93:(10):1996;4948-4952.
17. Torchia J., Rose D.W., Inostroza J., Kamei Y., Westin S., Glass C.K., Rosenfeld M.G. The transcriptional co-activator p/CIP binds CBP and mediates nuclear receptor function. Nature. 387:(6634):1997;677-684.
18. Williams G.R., Franklyn J.A. Physiology of the steroid-thyroid hormone nuclear receptor superfamily. Bailliere's Clin Endocrinol Metabol. 8:(2):1994;241-265.
19. Chandler V.L., Maler B.A., Yamamoto K.R. DNA sequences bound specifically by glucocorticoid receptor in vitro render a heterologous promoter hormone responsive in vivo. Cell. 33:(2):1983;489-499.
20. Mymryh J.S., Archer T.K. Dissection of progesterone receptor-mediated chromatin remodeling and transcriptional activation in vivo. Genes Dev. 9:(11):1995;1366-1376.
21. Ruh M.F., Dunn R. II, Ruh T.S. Interrelationships between nuclear structure and ligand activated intracellular response. Crit Rev Eukaryo Gene Exp. 6:(2-3):1996;271-283.
22. Giguere V., Hollenberg S.M., Rosenfeld M.G., Evans R.M. Functional domains of the human glucocorticoid receptor. Cell. 46:(5):1986;645-652.
23. Hollenberg S.M., Giguere V., Segui P., Evans R.M. Colocalization of DNA binding domain and transcriptional activation functions in the human glucocorticoid receptor. Cell. 49:(1):1987;39-46.
24. Dahlman-Wright K., Baumann H., McEwan I.J., Almlof T., Wright A.P.H., Gustafsson J.A., Hard T. Structural characterization of a minimal functional transactivation domain from the human glucocorticoid receptor. Proc Natl Acad Sci USA. 92:(5):1995;1699-1703.
25. Folkers G.E., van Heerde E.C., van der Saag P.T. Activation function of retinoic acid receptor β2 is an acidic activator resembling VP16. J Biol Chem. 270:(40):1995;23552-23559.
26. McEwan I.J., Wright A.P.H., Dahlman-Wright K., Carlstedt-Duke J., Gustafsson J.A. Direct interaction of the tau1 transactivation domain of the human glucocorticoid receptor with basal transcriptional machinery. Mol Cell Biol. 13:(1):1993;399-407.
27. Schmitz M.L., dos Santos Silva M.A., Altmann H., Czisch M., Holak T.A., Baeuerle P.A. Structural and functional analysis of NF-kappa B p65 C-terminus An acidic and modular transactivation domain with the potential to adopt an α-helical conformation . J Biol Chem. 269:(41):1994;25613-25620.
28. McEwan I.J., Dahlman-Wright K., Ford J., Wright A.P.H. Functional interaction of the c-myc transactivation domain with the TATA binding protein evidence for an induced fit model of transactivation domain folding . Biochem. 35:(29):1996;9584-9593.
29. Donaldson L., Capron J.P. Purification and characterization of the C-terminal transactivation domain of Vmw65 from herpes simplex virus type I. J Biol Chem. 267:(3):1992;1411-1414.
30. Lehrman S.R., Tuls J.L., Lund M. Peptide α-helicity in aqueous trifluoroethanol Correlation with predicted α-helicity and the secondary structure of the corresponding regions of bovine growth hormone . Biochem. 29:(23):1990;5590-5596.
31. Dyson H.J., Merutka G., Waltho P., Lerner R., Wright P.E. Folding of peptide fragments comprising the complete sequence of proteins. Models for initiation of protein folding. I. Myohemerythrin. J Mol Biol. 226:(3):1992;795-817.
32. Dyson H.J., Rance M., Houghten R.A., Wright P.E., Lerner R. Folding of immunogenic peptide fragments of proteins in water solution. II. The nascent helix. J Mol Biol. 201:(1):1992;201-217.
33. Tjian R., Maniatis T. Transcriptional activation a complex puzzle with few easy pieces . Cell. 77:(1):1994;5-8.
34. Henriksson A., Almlof T., Ford J., McEwan I.J., Gustafsson J.A., Wright A.P.H. Role of Ada adaptor complex in gene activation by the glucocorticoid receptor. Mol Cell Biol. 17:(6):1997;3065-3073.
35. Ford J., McEwan I.J., Wright A.P.H., Gustafsson J.A. Involvement of the transcription factor IID protein complex in gene activation by the N-terminal transactivation domain of the glucocorticoid receptor in vitro. Mol Endocrinol. 11:(10):1997;1467-1475.
36. Guarente L. Transcriptional activators in yeast and beyond. Trends Biochem Sci. 20:(12):1995;517-521.
37. Zeiner M., Gehring U. A protein that interacts with members of the nuclear hormone receptor family identification and cDNA cloning . Proc Natl Acad Sci USA. 92:(25):1995;11465-11469.
38. Onate S.A., Tsai S.Y., Tsai M.J., O'Malley B.W. Sequence and characterization of a coactivator for the steroid hormone receptor superfamily. Sci. 270:(5240):1995;1354-1357.
39. Chakravarti D., LaMorte V.J., Nelson M.C., Nakajima T., Schulman I.G., Jugiulon H., Montminy M., Evans R.M. Role of CBP/300 in nuclear receptor signalling. Nature. 383:(6595):1996;99-103.
40. Luisi B.F., Xu W.X., Otwinowski Z., Freedman L.P., Yamamoto K.R., Sigler P.B. Crystallographic analysis of the interaction of the glucocorticoid receptor with DNA. Nature. 352:(6335):1991;497-505.
41. Freedman L.P., Luisi B.F., Korszun Z.R., Basavappa R., Sigler P.B., Yamamoto K.R. The function and structure of the metal coordination sites within the glucocorticoid receptor DNA binding domain. Nature. 334:(6182):1988;543-546.
42. Freedman L.P., Yamamoto K.R., Luisi B.F., Sigler P.B. More fingers in hand. Cell. 54:(4):1988;444.
43. Miller J., McLachlan A.D., Klug A. Repetitive zinc-binding domains in the protein transcription factor IIIA from Xenopus oocytes. EMBO J. 4:(6):1985;1609-1614.
44. Brown R.S., Sander C., Angos P. The primary structure of transcription factor TFIIIA has 12 consecutive repeats. FEBS Lett. 186:(2):1985;271-274.
45. Klug A., Rhodes D. Zn fingers a novel protein motif for nucleic acid recognition . Trends Biochem Sci. 12:(12):1987;464-469.
46. Berg J.M. Proposed structure for the zinc-binding domains from transcription factor IIIA and related proteins. Proc Natl Acad Sci USA. 85:(1):1988;99-102.
47. Klevit R.E., Herriott J.R., Hovrath S.J. Solution structure of a zinc finger domain of yeast ADR1. Proteins. 7:(3):1990;215-226.
48. Hard T., Kellenbach E., Boelens R., Maler B.A., Dahlman K., Freedman L.P., Carlstedt-Duke J., Yamamoto K.R., Gustafsson J.A., Kaptein R. Solution structure of the DNA binding domain of the glucocorticoid receptor. Sci. 249:(4965):1990;157-160.
49. Baumann H., Paulsen K., Kovacs H., Berglund H., Wright A.P.H., Gustafsson J.A., Hard T. Refined solution structure of the glucocorticoid receptor DNA binding domain. Biochemistry. 32:(49):1993;13463-13471.
50. Freedman L.P. Anatomy of the steroid receptor zinc finger region. Endocrinol Rev. 13:(2):1992;129-145.
51. Schwabe J.W.R., Neuhaus D., Rhodes D. Solution structure of the oestrogen receptor. Nature. 348:(6300):1990;458-461.
52. Knegtel R.M.A., Katahira M., Schilthuis J.G., Bonvin A.M.J.J., Boclens R., Eib D., van der Saag P.T., Kaptein R. The solution structure of the human retinoic acid receptor-β DNA binding domain. J Biol NMR Res. 3:(1):1993;1-17.
53. Lee M.S., Kliewer S.A., Provencal J., Wright P.E., Evans R.M. Structure of the retinoid X receptor-α DNA binding domain a helix required for homodimeric DNA binding . Sci. 260:(5111):1993;1117-1121.
54. Schwabe J.W.R., Chapman L., Finch J.T., Rohdes D. The crystal structure of the estrogen receptor DNA binding domain bound to DNA how receptors discriminate between their response elements . Cell. 75:(3):1993;567-578.
55. 15N NMR relaxation measurements with a molecular dynamics simulation backbone dynamics of the glucocorticoid receptor DNA binding domain . Proteins. 17:(4):1993;375-390.
56. Berglund H., Kovacs H., Dahlman-Wright K., Gustafsson J.A., Hard T. Backbone dynamics of the glucocorticoid receptor DNA binding domain. Biochem. 31:(48):1992;12001-12011.
57. Rastinejad F., Perlmann T., Evans R.M., Sigler P.B. Structural determinants of nuclear receptor assembly on DNA direct repeats. Nature. 375:(6528):1995;203-211.
58. Ducouret B., Tujague M., Ashraf J., Mouchel N., Servel N., Valataire Y., Thompson E.B. Cloning of a teleost fish GR shows that it contains a DNA binding domain different from that of mammals. Endocrinol. 136:(9):1995;3774-3782.
59. Pakdel F., Guellec C.L., Vaillant C., Roux M.G.L., Valataire Y. Identification and estrogen induction of two estrogen receptors messenger ribonucleic acids in the rainbow trout liver sequence homology with other ERs . Mol Endocrinol. 3:(1):1989;44-51.
60. Brzozowski A.M., Piki A.C.W., Dauter Z., Hubbard R.E., Bonn T., Engstrom O., Ohman L., Greene G.L., Gustafsson J.A., Carlquist M. Molecular basis of agonism and antagonism in the oestrogen receptor. Nature. 389:(6652):1997;753-758.
61. Bourguet W., Ruff M., Chambon P., Gronemeyer H., Moras D. Crystal structure of the ligand binding domain of the human nuclear receptor RXR-α Nature. 375:(6530):1995;377-382.
62. Renaud J.P., Rochel N., Ruff M., Vivat V., Chambon P., Gronomeyer H., Moras D. Crystal structure of the retinoic acid receptor-γ ligand binding domain bound to all-trans retinoic acid. Nature. 378:(6558):1995;681-689.
63. Wagner R.L., Apriletti J.W., McGrath M.E., West B.L., Baxter J.D., Fletterick R.J. A structural role of hormone in the thyroid hormone receptor. Nature. 378:(6558):1995;690-697.
64. Wurtz J.M., Bourguet W., Renaud J.P., Vivat V., Chambon P., Moras D., Gronemeyer H. A canonical structure for the ligand binding domain of nuclear receptors. Nat Struct Biol. 3:(1):1996;87-94.
65. Klaholz B.P., Renaud J.P., Mitschler A., Zusi C., Chambon P., Gronemeyer H., Moras D. Conformational adaptation of agonists to the human nuclear receptor RAR-γ Nat Struct Biol. 5:(3):1998;199-202.
66. Green S., Chambon P. Nuclear receptors enhance our understanding of transcription regulation. Trends Genet. 4:(11):1988;309-314.
67. Nagpal S., Friant S., Nakashatri H., Chambon P. RARs and RXRs Evidence for two autonomous transactivation functions (AF-1 and AF-2) and heterodimerization in vivo . EMBO J. 12:(6):1993;2349-2360.
68. vom Baur E., Zechel C., Heery D., Heine M.J., Garnier J.M., Vivat V., Le Douarin B., Gronemeyer H., Chambon P., Losson R. Differential ligand dependent interactions between the AF2 activating domain of nuclear receptors and the putative transcriptional intermediary factors mSUG1 and TIF1. EMBO J. 15:(1):1996;110-124.
69. Tasset D., Tora L., Fromental C., Scheer E., Chambon P. Distinct classes of transcriptional activating domains function by different mechanisms. Cell. 62:(6):1990;1177-1187.
70. Danielian P.S., White R., Lees J.A., Parker M.G. Identification of a conserved region required for hormone dependent transcriptional activation by steroid receptors. EMBO J. 11:(3):1992;1025-1033.
71. McInerney E.M., Tsai M.J., O'Malley B.W., Katzenellenbogen B.S. Analysis of the estrogen receptor transcriptional enhancement by a nuclear hormone receptor coactivator. Proc Natl Acad Sci USA. 93:(19):1996;10069-10073.
72. Williams S, Wang Y, Tanenbaum DM, Sigler PB. Crystallographic comparison of hormone-bound progesterone and estrogen receptor ligand binding domains. In: The abstract book of Nuclear Gene Receptor Family. Incline Village, Nevada. 1998: pp. 108.
73. Xu HE, Lambert M, Montana V, Wisely GB, Gampe R, Sznaidman M, Sternbach D, Willson T, Milburn M. The PPAR delta ligand binding domain: Purification, crystallization and structure determination. In: The abstract book of Nuclear Gene Receptor Family. Incline Village, Nevada. 1998. pp. 89.
74. Williams S.P., Sigler P.B. Atomic structure of progesterone complexed with its receptor. Nature. 393:(6683):1998;392-396.
75. Tanenbaum D.M., Wang Y., Williams S.P., Sigler P.B. Crystallographic comparison of the estrogen and progesterone receptor's ligand binding domains. Proc Natl Acad Sci USA. 95:(11):1998;5998-6003.
76. Nolte R.T., Wisely G.B., Westin S., Cobb J.E., Lambert M.H., Kurokawa R., Rosenfeld M.G., Wilson T.M., Glass C.K., Milburn M.V. Ligand binding and co-activator assembly of the peroxisome proliferator-activated receptor-γ Nature. 395:(6698):1998;137-143.
77. Wood J.R., Greene G.L., Nardulli A.M. Estrogen response elements function as allosteric modulators of estrogen receptor conformation. Mol Cell Biol. 18:(4):1998;1927-1934.
78. Gandini O., Kohno H., Curtis S., Korach K. Two transcription activation functions in the amino terminus of the mouse estrogen receptor that are affected by the carboxy terminus. Steroids. 62:(7):1997;508-515.
79. Heery D.M., Kalkhoven E., Hoare S., Parker M.G. A signature motif in transcriptional coactivators mediates binding to nuclear receptors. Nature. 387:(6634):1997;733-736.
80. Masuyama H., Brownfield C.M., St-Arnaud K., MacDonald P.N. Evidence for ligand dependent intramolecular folding of the AF-2 domain in vitamin-D receptor activated transcription and coactivator interaction. Mol Endocrinol. 11:(10):1997;1507-1517.